4.7(top 3%)
Impact Factor
5.2(top 3%)
extended IF
62(top 6%)
H-Index
776
authors
902
papers
16.4K
citations
2.9K
citing journals
15.3K
citing authors

Most Cited Articles of Therapeutic Advances in Gastroenterology

TitleYearCitations
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation2013485
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ2013457
Diagnosis and management of iron deficiency anemia in the 21st century2011198
Pancreatic cancer: why is it so hard to treat?2013193
Overutilization of proton-pump inhibitors: what the clinician needs to know2012191
Fecal microbiota transplantation: in perspective2016186
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders2012173
Current status of novel antifibrotic therapies in patients with chronic liver disease2011148
Use of probiotics in gastrointestinal disorders: what to recommend?2010146
Secondary causes of nonalcoholic fatty liver disease2012139
The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?2013137
Fecal microbiota transplantation in relapsing Clostridium difficile infection2012134
Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection2011118
The emerging role of miRNAs in inflammatory bowel disease: a review2015111
Immunogenicity of biologics in inflammatory bowel disease2018110
The role and utility of faecal markers in inflammatory bowel disease2015109
The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial2009107
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions2016104
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?2012103
Treatment options for nonalcoholic fatty liver disease2010103
Treatment of alcoholic liver disease2011101
Managing bile acid diarrhoea201099
A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantation201495
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?201395
The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy201295